Results 151 to 160 of about 28,167 (192)
Some of the next articles are maybe not open access.
Nature Reviews Disease Primers, 2018
This corrects the article DOI: 10.1038/nrdp.2017.103.
Schreiber K. +9 more
openaire +6 more sources
This corrects the article DOI: 10.1038/nrdp.2017.103.
Schreiber K. +9 more
openaire +6 more sources
Pediatric Clinics of North America, 2005
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a combination of arterial or venous thrombosis and recurrent fetal loss, accompanied by elevated titers of antiphospholipid antibodies (aPL). APS has been recognized as the leading cause of vascular thrombosis in children.
RAVELLI, ANGELO, MARTINI, ALBERTO
openaire +3 more sources
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a combination of arterial or venous thrombosis and recurrent fetal loss, accompanied by elevated titers of antiphospholipid antibodies (aPL). APS has been recognized as the leading cause of vascular thrombosis in children.
RAVELLI, ANGELO, MARTINI, ALBERTO
openaire +3 more sources
The Lancet, 2010
The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental insufficiency. Other clinical manifestations are cardiac valvular disease, renal thrombotic microangiopathy, thrombocytopenia, haemolytic anaemia, and cognitive impairment ...
Ruiz-Irastorza, Guillermo +3 more
openaire +5 more sources
The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental insufficiency. Other clinical manifestations are cardiac valvular disease, renal thrombotic microangiopathy, thrombocytopenia, haemolytic anaemia, and cognitive impairment ...
Ruiz-Irastorza, Guillermo +3 more
openaire +5 more sources
Current Opinion in Rheumatology, 2006
To review the recently published studies that can guide physicians in the management of persistently antiphospholipid antibody (aPL)-positive patients.Two recent prospective randomized controlled trials of two intensities of warfarin concluded that both moderate and high-intensity anticoagulation are similarly protective in antiphospholipid syndrome ...
Doruk, Erkan, Michael D, Lockshin
openaire +2 more sources
To review the recently published studies that can guide physicians in the management of persistently antiphospholipid antibody (aPL)-positive patients.Two recent prospective randomized controlled trials of two intensities of warfarin concluded that both moderate and high-intensity anticoagulation are similarly protective in antiphospholipid syndrome ...
Doruk, Erkan, Michael D, Lockshin
openaire +2 more sources
Hematology, 2013
Abstract The antiphospholipid syndrome (APS) is defined by venous or arterial thrombosis and/or pregnancy morbidity in patients with persistent presence of antiphospholipid antibodies (aPLs). Catastrophic APS is the most severe form of APS, which is associated with rapid development of microvascular thrombosis resulting in multiorgan ...
openaire +2 more sources
Abstract The antiphospholipid syndrome (APS) is defined by venous or arterial thrombosis and/or pregnancy morbidity in patients with persistent presence of antiphospholipid antibodies (aPLs). Catastrophic APS is the most severe form of APS, which is associated with rapid development of microvascular thrombosis resulting in multiorgan ...
openaire +2 more sources
Thrombosis Research, 2017
The antiphospholipid syndrome (APS) is defined by the development of venous and/or arterial thromboses, often multiple, and pregnancy morbidity (mainly, recurrent fetal losses), in the presence of antiphospholipid antibodies (aPL). Some estimates indicate that the incidence of the APS is around 5 new cases per 100,000 persons per year and the ...
openaire +2 more sources
The antiphospholipid syndrome (APS) is defined by the development of venous and/or arterial thromboses, often multiple, and pregnancy morbidity (mainly, recurrent fetal losses), in the presence of antiphospholipid antibodies (aPL). Some estimates indicate that the incidence of the APS is around 5 new cases per 100,000 persons per year and the ...
openaire +2 more sources
Best Practice & Research Clinical Rheumatology, 2020
Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial, venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or pregnancy morbidity in the setting of documented persistent antiphospholipid antibodies that include the lupus anticoagulant, or moderate-high titer anticardiolipin, or anti ...
openaire +2 more sources
Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial, venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or pregnancy morbidity in the setting of documented persistent antiphospholipid antibodies that include the lupus anticoagulant, or moderate-high titer anticardiolipin, or anti ...
openaire +2 more sources
Progress in Cardiovascular Diseases, 2009
The antiphospholipid syndrome (APS) is an autoimmune systemic disease that is diagnosed when there is vascular thrombosis and/or pregnancy morbidity occurring with persistently positive antiphospholipid antibodies (aPL) (lupus anticoagulant test, anticardiolipin antibodies, and/or anti-beta(2)-glycoprotein I antibodies).
Diane, George, Doruk, Erkan
openaire +2 more sources
The antiphospholipid syndrome (APS) is an autoimmune systemic disease that is diagnosed when there is vascular thrombosis and/or pregnancy morbidity occurring with persistently positive antiphospholipid antibodies (aPL) (lupus anticoagulant test, anticardiolipin antibodies, and/or anti-beta(2)-glycoprotein I antibodies).
Diane, George, Doruk, Erkan
openaire +2 more sources
Antiphospholipid antibodies and antiphospholipid syndrome
Current Opinion in Rheumatology, 1995More than a decade has gone by since the detailed clinical description of antiphospholipid syndrome (APS). Thrombosis, the main complication of the syndrome, can affect vessels of all sizes; the consistent histopathologic lesion is a bland thrombus without inflammation.
M A, Khamashta, G R, Hughes
openaire +2 more sources
Pediatric Antiphospholipid Syndrome
Current Rheumatology Reports, 2015Antiphospholipid syndrome (APS) is a multisystem autoimmune condition characterized by vascular thromboses associated with persistently positive antiphospholipid antibodies. There is currently a paucity of data (incidence, prevalence, thrombosis risk, and effective treatment) in pediatric APS.
Cassyanne L, Aguiar +3 more
openaire +2 more sources